Yang Y M, Chang J W
Division of Uropathology, Tianjin Institute of Urologic Surgery, The Second Hospital of Tianjin Medical University, TianJin, PR China.
Cancer Invest. 2008 Aug;26(7):741-55. doi: 10.1080/07357900801901856.
Cancer stem cells (CSCs) have been positively identified and successfully isolated from some but not all cancers. The studies on CSCs to date suggest that these cells are rare among the tumor cell population, and they are capable of self-renewing and maintaining tumor growth and heterogeneity. Therapies aimed at CSCs have shown some promise, but their further development will require a more thorough understanding of the biology of CSCs and methods for identifying and isolating this cell subpopulation. This review examines what is known to date regarding the similarities and differences between cancer and somatic stem cells: CSC surface marker development and cell isolation (including a model isolation from our lab), the frequency, potential origin, and signal transduction of CSCs, and the current state of CSC-targeting therapeutic strategies.
癌症干细胞(CSCs)已在部分而非所有癌症中得到明确鉴定并成功分离。迄今为止,对癌症干细胞的研究表明,这些细胞在肿瘤细胞群体中较为罕见,并且它们能够自我更新并维持肿瘤生长及异质性。针对癌症干细胞的疗法已展现出一定前景,但其进一步发展需要对癌症干细胞生物学以及识别和分离该细胞亚群的方法有更深入的了解。本综述探讨了目前已知的癌症干细胞与体细胞干细胞之间的异同:癌症干细胞表面标志物的发展及细胞分离(包括我们实验室的一种模型分离方法)、癌症干细胞的频率、潜在起源、信号转导,以及针对癌症干细胞的治疗策略的当前状况。